New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test
Go back to New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test| Abbott Laboratories (NYSE: ABT) | Delayed: 88.18 -1.47 (1.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.65 | 52 Week High | $46.38 | |||
| Open | $89.62 | 52 Week Low | $36.00 | |||
| Day High | $90.29 | P/E | 58.79 | |||
| Day Low | $87.07 | EPS | $1.50 | |||
| Volume | 13,786,283 | |||||
